These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6814753)

  • 21. Selective cytotoxicity of a ricin A-chain-anti-carcinoembryonic antigen antibody conjugate for a human colon adenocarcinoma cell line.
    Griffin TW; Haynes LR; DeMartino JA
    J Natl Cancer Inst; 1982 Oct; 69(4):799-805. PubMed ID: 6956757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibody-ricin conjugate cytotoxic to cells expressing the common acute lymphoblastic leukemia antigen (CALLA).
    Pelham JM; Meyer BF; Herrmann RP; Davis RE; Raphael CL; Kraft N; Atkins RC
    Pathology; 1987 Apr; 19(2):124-30. PubMed ID: 2969499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oropharyngeal aspiration of ricin as a lung challenge model for evaluation of the therapeutic index of antibodies against ricin A-chain for post-exposure treatment.
    Pratt TS; Pincus SH; Hale ML; Moreira AL; Roy CJ; Tchou-Wong KM
    Exp Lung Res; 2007; 33(8-9):459-81. PubMed ID: 17994372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-ricin conjugates: a method of linkage which blocks the galactose binding site of ricin.
    Foxwell BM; Ross WC; Thorpe PE
    Behring Inst Mitt; 1984 May; (74):101-7. PubMed ID: 6477350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of syngeneic antitumor serum on mammary tumor in a syngeneic host.
    Shinoda H; Yamazaki M; Mizuno D
    Gan; 1977 Oct; 68(5):561-5. PubMed ID: 590680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
    Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
    Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidisialoganglioside ricin A-chain immunotoxins show potent antitumor effects in vitro and in a disseminated human neuroblastoma severe combined immunodeficiency mouse model.
    Gottstein C; Schön G; Tawadros S; Kube D; Wargalla-Plate UC; Hansmann ML; Wacker HH; Berthold F; Diehl V; Engert A
    Cancer Res; 1994 Dec; 54(23):6186-93. PubMed ID: 7954465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of two anti-tumour monoclonal antibody preparations.
    Price MR; Dennick RG; Fang CY; Hannant D; Embleton MJ; Gunn B; Baldwin RW
    Arch Geschwulstforsch; 1981; 51(4):302-9. PubMed ID: 6947720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
    J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Target-selective cytotoxicity of methotrexate conjugated with monoclonal anti-MM46 antibody.
    Endo N; Takeda Y; Kishida K; Kato Y; Saito M; Umemoto N; Hara T
    Cancer Immunol Immunother; 1987; 25(1):1-6. PubMed ID: 3496155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
    Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: rate of lymphoid infiltration and distribution of T lymphocytes in tumors.
    Ben-Hur H; Kossoy G; Zandbank J; Zusman I
    Int J Mol Med; 2002 Apr; 9(4):425-30. PubMed ID: 11891540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
    Lee J; Fassnacht M; Nair S; Boczkowski D; Gilboa E
    Cancer Res; 2005 Dec; 65(23):11156-63. PubMed ID: 16322266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically targeted T cells eradicate established breast cancer in syngeneic mice.
    Wang H; Wei H; Zhang R; Hou S; Li B; Qian W; Zhang D; Kou G; Dai J; Guo Y
    Clin Cancer Res; 2009 Feb; 15(3):943-50. PubMed ID: 19188165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral & cell mediated immunity to leukemia specific antigens in an inbred mouse strain showing spontaneous leukemia & mammary tumors.
    Vissa B; Gangal SG
    Indian J Exp Biol; 1974 Jan; 12(1):12-4. PubMed ID: 4426641
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug/antibody conjugates. In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.
    Endo N; Kato Y; Takeda Y; Saito M; Umemoto N; Kishida K; Hara T
    Acta Paediatr Jpn; 1987 Aug; 29(4):566-8. PubMed ID: 3144892
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cytotoxic properties of an immunotoxin interacting with mouse myeloma cells].
    Tonevitskiĭ AG; Trakht IN
    Dokl Akad Nauk SSSR; 1984; 277(3):756-9. PubMed ID: 6386405
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
    Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J
    Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
    Kawata A; Yoshida M; Okazaki M; Yokota S; Barcos M; Seon BK
    Cancer Res; 1994 May; 54(10):2688-94. PubMed ID: 8168098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and in vitro cytotoxicity of a methotrexate-anti-MM46 monoclonal antibody conjugate via an oligopeptide spacer.
    Umemoto N; Kato Y; Endo N; Takeda Y; Hara T
    Int J Cancer; 1989 Apr; 43(4):677-84. PubMed ID: 2784785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.